Mesangial myofibroblastic transformation in steroid-dependent minimal change nephrotic syndrome

被引:2
|
作者
Naruse K. [1 ]
Fujieda M. [1 ]
Miyazaki E. [1 ]
Hayashi Y. [1 ]
Toi M. [1 ]
Kuroda N. [1 ]
Hiroi M. [1 ]
Kurashige T. [1 ]
Enzan H. [1 ]
机构
[1] First Department of Pathology, Kochi Medical School, Nankoku 783-8505, Kohasu Okohcho
来源
Medical Electron Microscopy | 2000年 / 33卷 / 2期
关键词
αSmooth muscle actin; Immunohistochemistry; Minimal change nephrotic syndrome; Vimentin;
D O I
10.1007/s007950070009
中图分类号
学科分类号
摘要
Patients with minimal change nephrotic syndrome (MCNS) occasionally show frequent relapses with proteinuria after cessation of steroid treatment, even though no significant pathological abnormalities are found in the glomeruli, compared with those in nonrelapsed and good-prognosis cases of MCNS. To resolve this contradiction, we immunohistochemically and ultrastructurally examined a biopsied renal tissue of a patient who showed glomerular features of MCNS and frequent clinical relapses. Immunohistochemistry demonstrated the overexpression of a-smooth muscle actin (ASMA) and vimentin in glomerular mesangial cells despite no mesangial cell proliferation, compared with nine nonrelapsed cases of MCNS. These facts may be an important clue to the investigation of the pathogenesis of steroid-dependent MCNS with frequent relapses. Furthermore, the immunohistochemical examination of ASMA and vimentin may be useful to detect mesangial myofibroblastic transformation that is not demonstrated in conventional light microscopy and immunofluorescence study.
引用
收藏
页码:102 / 107
页数:5
相关论文
共 50 条
  • [1] Tacrolimus effective in steroid-dependent minimal change nephrotic syndrome
    不详
    Nature Clinical Practice Nephrology, 2008, 4 (1): : 5 - 6
  • [2] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
    Rodney D. Gilbert
    Eleanor Hulse
    Susan Rigden
    Pediatric Nephrology, 2006, 21 : 1698 - 1700
  • [3] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
    Gilbert, Rodney D.
    Hulse, Eleanor
    Rigden, Susan
    PEDIATRIC NEPHROLOGY, 2006, 21 (11) : 1698 - 1700
  • [4] STEROID-DEPENDENT NEPHROTIC SYNDROME WITH MINIMAL GLOMERULAR CHANGES AND MESANGIAL IGA DEPOSITS
    GALLEGO, N
    GONZALO, A
    MAMPASO, F
    ORTUNO, J
    CHILD NEPHROLOGY AND UROLOGY, 1989, 9 (1-2) : 98 - 100
  • [5] Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome
    Niu, Xiao-Ling
    Hao, Sheng
    Wang, Ping
    Zhang, Wei
    Guo, Gui-Mei
    Wu, Ying
    Kuang, Xin-Yu
    Zhu, Guang-Hua
    Huang, Wen-Yan
    BIOMEDICAL REPORTS, 2016, 5 (02) : 237 - 242
  • [6] Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil
    Noroña, B
    Valentín, M
    Gutiérrez, E
    Praga, M
    NEFROLOGIA, 2004, 24 (01): : 79 - 82
  • [7] A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria
    Jonkers, IJ
    Bruijn, JA
    Vleming, LJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (04) : 773 - 777
  • [8] Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
    Hofstra, Julia M.
    Deegens, Jeroen K. J.
    Wetzels, Jack F. M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (07) : 2100 - 2102
  • [9] Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome
    Li, Xiayu
    Li, Heng
    Chen, Jianghua
    He, Qiang
    Lv, Rong
    Lin, Weiqin
    Li, Qun
    He, Xuelin
    Qu, Lihui
    Suya, Wang
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (06) : 1919 - 1925
  • [10] STEROID-DEPENDENT NEPHROTIC SYNDROME
    ARANT, BS
    SINGER, SA
    BERNSTEIN, J
    JOURNAL OF PEDIATRICS, 1982, 100 (02): : 328 - 333